Live Breaking News & Updates on ராபர்ட் ப்ரேந்டிஸ்ஸ்

Stay updated with breaking news from ராபர்ட் ப்ரேந்டிஸ்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Aclaris Therapeutics (NASDAQ:ACRS) - The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Aclaris Therapeutics (NASDAQ:ACRS) - The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Neurocrine Biosciences , Harvard Biosciences , John Schroer , Robert Prentiss , Harvard Bioscience Inc , Regenxbio Inc , Supernus Pharmaceuticals Inc , Virios Therapeutics , Cellectar Biosciences Inc , Gilead Sciences Inc , Halozyme Therapeutics Inc , Merck Co Inc , Pfizer Inc , Spectrum Pharmaceuticals Inc , Soligenix Inc , Neurocrine Biosciences Inc , Voyager Therapeutics Inc , Inhibikase Therapeutics Inc , European Commission , Bio Inc , Sorrento Therapeutics Inc , Roche Holdings Ag Basel , Histogen Inc , Immunome Inc , Biotech Stocks Hitting , Common Stock ,

Translate Bio Announces Departure of Chief Financial Officer

Translate Bio Announces Departure of Chief Financial Officer
LEXINGTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, announced today that John Schroer, the Company’s Chief Financial Officer (CFO), is departing the Company for personal reasons. Mr. Schroer’s departure will be effective by year-end 2020. Robert Prentiss, Translate Bio’s Vice President and Corporate Controller since 2017, will serve as Principal Accounting Officer and report directly to the Company’s Chief Executive Officer, Ronald Renaud, on an interim basis while a formal search process to appoint a new CFO is conducted. ....

Sanofi Pasteur , Teri Dahlman , John Schroer , Maura Gavaghan , Ronald Renaud , Robert Prentiss , Translate Bio , Chief Financial Officer , Vice President , Corporate Controller , Principal Accounting Officer , Chief Executive Officer , Bay Area , சனோஃபி பாஸ்டர் , தேறி டால்மேன் , ஜான் ஸ்ச்சிரோேர் , ரொனால்ட் ரிநோ , ராபர்ட் ப்ரேந்டிஸ்ஸ் , மொழிபெயர் உயிர் , தலைமை நிதி அதிகாரி , துணை ப்ரெஸிடெஂட் , பெருநிறுவன கட்டுப்படுத்தி , ப்ரிந்ஸிபல் கணக்குவைப்பு முறை அதிகாரி , தலைமை நிர்வாகி அதிகாரி , வளைகுடா பரப்பளவு ,